Preview

Healthcare

Healthcare

Advanced search

Precision medicine and digital technologies in reproductive, maternal and child health: global trends and scientific research in the Republic of Belarus

https://doi.org/10.65249/1027-7218-2026-9-4-15

Abstract

Objective. To analyse current global trends in scientific research in obstetrics and gynaecology, neonatology, paediatrics and medical genetics and to substantiate priority directions for national science in these fields of medicine.

Materials and methods. A scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items For Systematic Reviews And Meta-Analyses Extension For Scoping Reviews) methodology. Searches were performed in PubMed, Scopus and Web of Science for the period January 2019  –  July 2026 (last search date: 31 July 2026). The search query combined the terms “precision medicine”, “artificial intelligence”, “machine learning”, “preeclampsia”, “fetal growth restriction”, “assisted reproduction”, “endometrial receptivity”, “newborn screening”, and “prenatal exome/genome sequencing” using AND/OR operators. Inclusion criteria: original studies, systematic reviews and meta-analyses in English or Russian. Exclusion criteria: individual case reports and publications without full-text access. National and international policy documents were additionally analysed. Source selection was performed independently by three reviewers; data synthesis was qualitative (narrative) with thematic grouping.

Results. The key vectors of global perinatal medicine transformation were identified: application of artificial intelligence for early detection of pregnancy complications (AUC = 0.85–0.95 in pre-eclampsia and fetal growth restriction prediction systems); expansion of genomic neonatal screening to cover more than 36 conditions; implementation of exome and genome sequencing in prenatal diagnosis (incremental diagnostic yield 11.0–29.5 % compared with chromosomal microarray analysis); and personalisation of assisted reproductive technologies based on multiparametric omics studies. The achievements of the Republic of Belarus in 2025 (infant mortality 2.4 ‰, perinatal mortality 3.68 ‰, survival rate of extremely low birth weight newborns 84.0 %) are consistent with global trends.

Conclusion. The implementation of the subprogram “Obstetrics, Gynecology, Pediatrics and Medical Genetics” of the State Scientific and Technical Program “Innovative Technologies in Medicine” (2026–2030) is aimed at advancing translational research and integrating precision medicine technologies into clinical practice.

About the Authors

S. Vasilyev
Республиканский научно-практический центр «Мать и дитя»
Belarus


E. Ulezko
Республиканский научно-практический центр «Мать и дитя»
Belarus


I. Kurlovich
Республиканский научно-практический центр «Мать и дитя»
Belarus


References

1. Gbagbo F.Y., Ameyaw E.K., Yaya S. Artificial intelligence and sexual reproductive health and rights: a technological leap towards achieving sustainable development goal target 3.7. Reprod Health. 2024; 21(1). doi: 10.1186/s12978-024-01924-9.

2. Infertility workup for the women’s health specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol. 2019; 133(6). doi: 10.1097/AOG.0000000000003271.

3. National Statistical Committee of the Republic of Belarus. Data Portal [Internet]. Minsk: Belstat; 2026. Available at: https://dataportal.belstat.gov.by (accessed: 17.08.2026).

4. Liu L., Zhu Q., Zong Y., et al. Machine learning prediction models for preeclampsia. J Med Internet Res. 2026; 28. doi: 10.2196/78714.

5. Wang J., Chen Z., Zhang H., et al. A machine learning model based on placental magnetic resonance imaging and clinical factors to predict fetal growth restriction. BMC Pregnancy Childbirth. 2025; 25. doi: 10.1186/s12884-025-07450-1.

6. Espinoza J., Calsavara V.F., Kilpatrick S., et al. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing. Am J Obstet Gynecol. 2024; 231(3). doi: 10.1016/j.ajog.2024.05.050.

7. Hackeloer M., Schmidt L., Verlohren S. New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring. Arch Gynecol Obstet. 2022; 308(6): 1663–1677.

8. Ozcan M., Peker S. Preeclampsia prediction via machine learning. Health Syst. 2025; 14(3): 208–222.

9. Kramko D.A., Artamonava V.V., Devyaltovskaya M.G. Questions of the usage of artificial intelligence in modern science and medicine (literature review). Sovremennye perinatal'nye medicinskie tekhnologii v reshenii problem demograficheskoj bezopasnosti. Minsk. 2024; 17: 282–286. (in Russian)

10. Yunas M., Islam M., Sindhu K., et al. Causes of and risk factors for postpartum haemorrhage. Lancet. 2025; 405. doi:10.1016/S0140-6736(25)00448-9.

11. Munoz M., Stensballe J., Ducloy-Bouthors A.S., et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 2019; 17(2): 112–136.

12. Goshkevich E.A., Peresada O.A., Vashchilina T.P. The relevance of diagnostic problems and the choice of delivery tactics for women with placenta increment (literature review). Covremennye perinatal'nye medicinskie tekhnologii v reshenii problem demograficheskoj bezopasnosti. Minsk. 2024; 17: 66–74. (in Russian)

13. Kaserer A., Castellucci C., Henckert D., et al. Patient blood management in pregnancy. Transfus Med Hemother. 2023; 50(3): 245–255.

14. Lacconi V., Massimiani M., Carriero I., et al. When the embryo meets the endometrium: identifying the features required for successful embryo implantation. Int J Mol Sci. 2024; 25(5). doi: 10.3390/ijms25052834.

15. Chen C.-H., Lee C.-I., Huang C.-C., et al. Increased incidence of live births in implanted single-embryo transfer cycles of vitrifiedwarmed blastocysts expanded on day 5 versus day 6 following preimplantation genetic testing for aneuploidy. Sci Rep. 2023; 13. doi: 10.1038/s41598-023-40052-5.

16. Toporcerova S., Spakova I., Soltys K., et al. Small non-coding RNAs as new biomarkers to evaluate the quality of the embryo in the IVF process. Biomolecules. 2022; 12(11). doi: 10.3390/biom12111687.

17. Ruiz-Alonso M., Gomez C., Stankewicz T., et al. Clinical outcomes following endometrial receptivity assessmentguided personalized euploid embryo transfer in patients with previous implantation failures. Sci Rep. 2025; 15(1). doi: 10.1038/s41598-025-01056-5.

18. Liu Z., Liu X., Wang M., et al. The clinical efficacy of personalized embryo transfer guided by the endometrial receptivity array/analysis on IVF/ICSI outcome. Front Physiol. 2022; 13. doi: 10.3389/fphys.2022.841437.

19. Chae-Kim J., Doyle N., Jahandideh S., et al. Evaluating the endometrial receptivity assay. Fertility Sterility. 2022; 120(6): 1255–1256.

20. Marzanati D., Ranucci F., Pagliardini L., et al. Endometrial receptivity profiled through transcriptomic analysis of uterine fluid extracellular vesicles using systems biology and bayesian modeling for pregnancy prediction. Sci Rep. 2025; 15(1). doi:10.1038/s41598025-19633-z.

21. Caporali C., Longo S., Tritto G., et al. Neurodevelopmental outcome of Italian preterm ELBW infants: an eleven years single center cohort. Ital J Pediatr. 2022; 48(1): doi: 10.1186/s13052-022-01303-9.

22. Baker S., Kandasamy Y. Machine learning for understanding and predicting neurodevelopmental outcomes in premature infants. Pediatr Res. 2023; 93(2): 293–299.

23. Na J.Y., Jung D., Cha J.H., et al. Learning-based longitudinal prediction models for mortality risk in very-low-birth-weight infants. Neonatology. 2023; 120(5): 652–660.

24. Li A., Mullin S., Elkin P.L. Improving prediction of survival for extremely premature infants born at 23 to 29 weeks gestational age in the neonatal intensive care unit. JMIR Med Inform. 2024; 12. doi: 10.2196/42271.

25. Lewis J.D., Miran A.A., Stoolper M., et al. Neuroprognostication via spatially-informed machine learning following hypoxicischemic injury. medRxiv 2025. doi: 10.1101/2025.01.08.25320190.

26. Keles E., Bagci U. The past, current, and future of neonatal intensive care units with artificial intelligence. npj Digit Med. 2023; 6(1). doi.org/10.1038/s41746-023-00941-5.

27. Mastromoro G., Guadagnolo D., Khaleghi Hashemian N., et al. Molecular approaches in fetal malformations, dynamic anomalies and soft markers: diagnostic rates and challenges. Diagnostics. 2022; 12(3). doi: 10.3390/diagnostics12030575.

28. Fu F., Li R., Yu Q., et al. Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses. Genome Med. 2022; 14(1). doi: 10.1186/s13073-022-01130-x.

29. Shreeve N., Sproule C., Choy K.W., et al. Incremental yield of whole-genome sequencing over chromosomal microarray analysis and exome sequencing for congenital anomalies in prenatal period and infancy. Ultrasound Obstet Gynecol. 2024; 63(1): 15–23.

30. Wapner R.J., Giordano J.L., De Voest J., et al. Multicenter, prospective cohort of genome sequencing in 750 fetal structural anomalies. Am J Obstet Gynecol. 2024; 230(1). doi: 10.1016/j.ajog.2023.11.015.

31. Qin Y., Yao Y., Liu N., et al. Prenatal whole-exome sequencing for fetal structural anomalies. BMC Med Genomics. 2023; 16(1). doi: 10.1186/s12920-023-01697-3

32. Makhamreh M.M., Chong M.L., Van Den Veyver I.B. Advancements in prenatal genetic screening and testing: emerging technologies and evolving applications. Diagnostics. 2025; 15(20). doi: 10.3390/diagnostics15202579.

33. Rahimzadeh V., Friedman J.M., De Wert G., Knoppers B.M. Exome/genome-wide testing in newborn screening. Front Genet. 2022; 13. doi: 10.3389/fgene.2022.865400.

34. Chen T., Fan C., Huang Y., et al. Genomic sequencing as a first-tier screening test and outcomes of newborn screening. JAMA Netw Open. 2023; 6(9). doi: 10.1001/jamanetworkopen.2023.31162.

35. Boemer F., Hovhannesyan K., Piazzon F., et al. Population-based, first-tier genomic newborn screening in the maternity ward. Nat Med. 2025; 31(4): 1339–1350.

36. Saier C., Sansen S., Berghout J., et al. TREAT. Orphanet J Rare Dis. 2025; 20(1). doi: 10.1186/s13023-025-03692-6.

37. Fecarotta S., Vaccaro L., Verde A., et al. Combined biochemical profiling and DNA sequencing in the expanded newborn screening for inherited metabolic diseases. Orphanet J Rare Dis. 2025; 20(1). doi: 10.1186/s13023-025-03546-1.


Review

For citations:


Vasilyev S., Ulezko E., Kurlovich I. Precision medicine and digital technologies in reproductive, maternal and child health: global trends and scientific research in the Republic of Belarus. Healthcare. 2026;1(9):4-15. (In Russ.) https://doi.org/10.65249/1027-7218-2026-9-4-15

Views: 155

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)